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Introduction
Spray drying has previously been shown to be an effective method to produce cocrystals from both congruently and incongruently saturating solutions (Alhalaweh and Velaga, 2010) . It can offer an advantage compared to other solution based methods such as cooling crystallisation, which can result in a mixture of phases (Fucke et al., 2012) . Further to this, spray drying is favourable as it is a scalable, continuous one-step process often employed in the pharmaceutical industry (Broadhead et al., 1992; do Amaral et al., 2018) . Spray drying parameters can also be altered to tailor the properties of particles produced by spray drying, such as particle size, shape and density (Vehring et al., 2007) . However, disadvantages of spray drying include the requirement of large volumes of organic solvent (Ré, 2006) , residual solvent of spray dried powders (Patel et al., 2009) , the production of poorly flowable powders (Walton, 2000) and the expense of the equipment at large scale.
Hot melt extrusion (HME) has been explored as a method to produce cocrystals (Dhumal et al., 2010; Li et al., 2017; Moradiya et al., 2014) . This process can offer a number of advantages as a formulation processing method, as it is a scalable and continuous process. Unlike spray drying, it is a solvent free method, and is therefore often regarded as a 'greener' method in comparison to spray drying, as large volumes of solvent are not required. As a result, the product obtained will have negligible amounts of oxygen and water, an advantage for pharmaceuticals which are susceptible to oxidation and hydrolysis (Breitenbach, 2002; Li et al., 2013) . However, extrusion can also confer a number of disadvantages, as heat stress and shear force can cause chemical degradation of an active pharmaceutical ingredient (API) (Crowley et al., 2007) . In the case of cocrystallisation (processing of https://doi.org/10.1016/j.ijpharm.2018.09.029 Received 27 April 2018; Received in revised form 28 August 2018; Accepted 12 September 2018 drug and coformer) by extrusion, it has previously been demonstrated that cocrystallisation can occur when processed above the eutectic temperature (Dhumal et al., 2010) .
Ibuprofen (IBU) is a Non-Steroidal Anti-Inflammatory Drug (NSAID) included in Class II of the Biopharmaceutics Classification System (BCS), demonstrating poor aqueous solubility and high permeability (Alvarez et al., 2011) . Various attempts to increase the bioavailability of IBU, such as salt formation (Tung et al., 1991) and the formation of amorphous dispersions (Marsac et al., 2009; Shen et al., 2010) , are abundant in the literature. Cocrystallisation of IBU can offer an alternative formulation approach to increase the bioavailability of the API without altering the chemical integrity, while maintaining the physical stability of the API. Cocrystals of ibuprofen with a number of different coformers have been generated by methods such as solvent evaporation (Chow et al., 2012) , cooling crystallisation (Friščić and Jones, 2007) , liquid assisted grinding (Friščić and Jones, 2007) , dry grinding (Alshahateet, 2010 (Alshahateet, , 2011 , HME (Dhumal et al., 2010; Kelly et al., 2012; Moradiya et al., 2014) , and freeze drying (Eddleston et al., 2013) . A review of the literature revealed no previous reports of an IBU cocrystal produced by spray drying.
We have previously described the production of cocrystals of another BCS Class II drug, sulfadimidine, in the presence of a third component by a one-step spray drying process in order to reduce the number of unit operations which are required to produce a final pharmaceutical product . Cocrystal integrity was preserved when the cocrystal components were immiscible with the excipient, based on the difference in Hansen Solubility Parameter (HSP). However, our previous work did not consider the use of HME as an alternative continuous process to produce a cocrystal-in-excipient matrix system. Attempts have previously been made to form the IBU:INA cocrystal by HME in the presence of xylitol, Soluplus and Eudragit EPO (Li et al., 2016) . Cocrystal formation occurred only in the presence of xylitol (which has a melt temperature of 93.68°C) at a 90:10 weight ratio of cocrystal components to xylitol, but not with Soluplus or Eudragit EPO, probably due to IBU amorphisation during the extrusion process (Li et al., 2016) . Ratios of 70:30 and 50:50 (by weight) of cocrystal components to xylitol resulted in cocrystal formation, but individual crystalline IBU and INA were also detected in the extruded products. However, alteration of the processing temperature and screw configuration during extrusion led to cocrystal formation even with a higher xylitol load of 50% by weight (Li et al., 2017) .
The aim of this work was to fully investigate the impact of including a carrier excipient on cocrystal formation during spray drying and to compare it to HME. Spray drying and HME techniques have previously been compared in the context of the production of amorphous solid dispersions (Tian et al., 2014) and fixed dose combinations (Kelleher et al., 2018) , but the production of cocrystals in an excipient matrix by both methods has not been compared. The combination of IBU:INA was used as model cocrystal. A range of pharmaceutical excipients was selected for processing. The ratio of cocrystal components to excipient was altered to assess the ratios at which cocrystal formation occurs. Due to the low melt temperature of xylitol and the low yield of xylitol on spray drying, mannitol (a six carbon polyol which is amenable to spray D. Walsh et al. International Journal of Pharmaceutics 551 (2018) [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] drying and has a similar HSP to xylitol, Table 2 ) was chosen as a model crystalline excipient for spray drying. Soluplus and PVP K15 were selected as amorphous excipients for comparison purposes. Solid state characterisation was performed as well as intrinsic dissolution studies from constant surface area discs to compare the product characteristics of materials processed by the two different methods.
Materials and methods

Materials
Racemic ibuprofen (IBU) was purchased from Kemprotec (Cumbria, U.K.). INA, mannitol and PVP K15 (average molecular weight 10,000) were obtained from Sigma-Aldrich (Wicklow, Ireland). Xylitol was purchased from Lancaster (Morecambe, England). Soluplus was a gift from BASF Corporation (Ludwugshafen, Germany). Chemical structures of the cocrystal components and excipients are illustrated in Fig. 1 . Ethanol was supplied by Corcoran Chemicals (Dublin, Ireland). Methanol, HPLC grade, was purchased from Sigma-Aldrich (Wicklow, Ireland). Water, analytical grade, was prepared from an Elix 3 connected to a Synergy UV system (Millipore, UK). All other chemicals used were of analytical grade.
Methods
Preparation of the cocrystal by solvent evaporation
IBU (2.06 g) and INA (1.22 g) were added to a beaker containing 50 ml of isopropanol as solvent. Sonication was performed to ensure complete dissolution of the API and coformer. The beaker was covered with pierced parafilm, which was placed in a fumehood and left to evaporate.
2.2.2. Preparation of the cocrystal and cocrystal-in-excipient systems by spray drying and hot melt extrusion Nomenclature. Each formulation is named in the text with reference to the method of production (spray drying (SD) or hot melt extrusion (HME)), excipient used (M = mannitol, X = xylitol, P = PVP K15 and S = Soluplus) and excipient weight fraction. For example, the co-spray dried system with 10% mannitol is referred to as SD-M-10.
2.2.2.1. Preparation of the cocrystal by spray drying. For the cocrystal alone, a 1% w/v solution of IBU:INA (1:1 M ratio) was prepared in ethanol or isopropanol (300 ml) and sonicated until completely dissolved. For the systems containing the cocrystal components and an excipient, a 1:1 M ratio of IBU:INA was dissolved in a mixture of ethanol and water at a 90:10 v/v ratio. When the two cocrystal components were fully dissolved, the carrier excipient was then added and fully dissolved. For the system containing 50 % w/w of excipient, the ratio of ethanol to water was altered to 80:20 v/v to ensure complete dissolution of the excipient. The batch size for all experiments performed by spray drying was 3 g (300 ml of a 1 % w/v solution). Solutions were spray dried using a Büchi B-290 Mini Spray Dryer operating in the open mode (inlet temperature 90°C, pump speed 30 % (equivalent to 9-10 ml/min), aspirator 100 % (equivalent to 35 m 3 /hr), nitrogen flow rate 667 Normlitres/h) . The spray dried cocrystal refers to the cocrystal spray dried from ethanol, unless indicated otherwise.
For comparison purposes, physical mixtures of cocrystal and excipients were prepared using an agate pestle and mortar.
A solution of INA and Soluplus 50:50 wt ratio was dissolved in a mixture of 90:10 v/v of ethanol and water and spray dried under the same spray drying conditions. A 1 %w/v solution of IBU was spray dried using ethanol as solvent. The inlet temperature was set at 65°C due to the low melt temperature of IBU. All other processing conditions were kept the same.
2.2.2.2. Negative controls -Spray drying. IBU or INA was spray dried with mannitol to investigate the possible formation of a cocrystal between the API or coformer with the crystalline excipient. IBU was spray dried with mannitol at a weight ratio of 0.566: 0.1, which is the same ratio of IBU:mannitol used in the formulation comprising 90:10 (w/w) cocrystal components to excipient. INA was also spray dried with mannitol at a weight ratio of 0.334:0.1. All process parameters were unchanged. The solvent used was a mixture of 90:10 v/v ethanol and water.
2.2.2.3. Preparation of the cocrystal by hot melt extrusion. A 1:1 M ratio of IBU and INA was premixed with either xylitol, Soluplus or PVP K15 using a mortar and pestle for 5 min. The ratio of cocrystal components to excipient was 90:10 (w/w). HME was performed using a co-rotating, fully intermeshing twin-screw extruder (Microlab, Rondol Technology Ltd, France). The extruder die (Rondol Technology Ltd, France) was 2 mm in diameter, and was connected via screws to the end of the barrel. Only conveying elements were assembled on the screw shafts. The extruder contained five heating zones, which were set at 70, 80, 90, 90 and 80°C from the feeding zone to the exit die. The batch size used was 10 g for all extrusion studies. The cylindrical extrudate was air cooled and subsequently cryomilled.
2.2.2.4. Negative controls -Hot melt extrusion. IBU or INA was extruded with xylitol to investigate the possible formation of a cocrystal between the API or coformer with the crystalline excipient. IBU was extruded with xylitol at a weight ratio of 0.566:0.1, which is the same ratio of IBU:xylitol used in the formulation comprising 90:10 (w/w) cocrystal components to excipient. INA was hot melt extruded with xylitol at a weight ratio of 0.334:0.1. All process parameters were unchanged.
2.2.2.5. Cryomilling. HME samples were pulverised using a high-energy cryogenic ball mill (Retsch Cryomill, Haan, Germany) with circulating liquid nitrogen for 3 cycles consisting of 5 min of grinding followed by a 2-minute break before physicochemical analysis.
2.2.3. Solid state characterisation 2.2.3.1. Single crystal X-ray diffraction. X-ray structural analysis for crystals of IBU:INA (C 19 H 24 N 2 O 3 ), prepared by solvent evaporation from isopropanol, was performed on a Bruker APEX Duo CCD at 100 K with an Oxford Cobra cryostat, with the sample mounted on a MiTeGen microloop using Cu Kα radiation (λ = 1.54178 Å). Bruker APEX (Bruker, 2014) software was used to collect and reduce data and determine the space group. Absorption corrections were applied using SADABS (Bruker, 2014/5) . Structures were solved with the XT structure solution program (Sheldrick, 2015) , using Intrinsic Phasing and refined with the XL refinement package (Sheldrick, 2008) using Least Squares minimisation. All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were assigned to calculated positions using a riding model with appropriately fixed isotropic thermal parameters, except for amide hydrogens (N1, N25) which were located on the difference map and refined as semi-free. The sample was weakly diffracting leading to a high wR 2 and poor high angle data. Apart from the acid moiety, each ibuprofen group is fully disordered and is modelled in two positions with O10/O12 64:36% and O34/O36 53:47% occupancy, and restraints were used for convergence of the least squares refinements (DFIX, SADI, SIMU). Crystallographic data, CCDC 1862812, can be obtained free of charge from the Cambridge Crystallographic Data Centre via www. ccdc.cam.ac.uk/data_request/cif. 2.2.3.2. Powder X-ray diffraction. Powder X-ray analysis (PXRD) was performed as previously described ) using a wideangle Miniflex II Rigaku™ diffractometer with Ni-filtered Cu Kα radiation (1.54 Å). The tube voltage and tube current used were 30 kV and 15 mA, respectively. The PXRD patterns were recorded (n = 3) for 2 theta ranging from 5°to 40°at a step scan rate of 0.05°D per second. Rigaku Peak Integral software was used to determine peak intensity for each sample using the Sonneveld-Visser background edit procedure.
The programme Mercury (version 3.9, Cambridge Crystallographic Data Centre, Cambridge, UK) was used for calculation of X-ray powder patterns on the basis of the single crystal structure.
2.2.3.3. Differential scanning calorimetry (DSC). DSC was performed as previously described ) using a Mettler Toledo DSC 821e instrument under nitrogen purge. Powder samples (3-6 mg) were placed in aluminium pans (40 μL), sealed, pierced to provide three vent holes and heated at a rate of 10°C/min in the temperature range of 25-200°C. Temperature and enthalpy were calibrated using indium as standard. The DSC was controlled by Mettler Toledo STARe software (version 6.10) working on a Windows NT operating system. All temperature values refer to onset temperature. Each measurement was performed in triplicate.
2.2.3.4. Modulated differential scanning calorimetry (MDSC). MDSC scans were performed using a DSC Q200 (TA Instruments, United Kingdom) with nitrogen as the purge gas. Samples were loaded into sealed standard aluminium pans, held at 105°C for 10 min to remove any residual moisture and scanned over a temperature range of 25-180°C with a modulation rate of 0.53°C every 40 s, with a scanning rate of 5°C/min. The instrument was calibrated for temperature and cell constant using high purity indium. MDSC data was analysed using TA Universal Analysis software (TA Instruments, Leatherhead, UK) version 4.5 A. Each measurement was performed in triplicate.
2.2.3.5. Thermogravimetric analysis (TGA). TGA was performed using a Mettler TG50 measuring module coupled to a Mettler Toledo MT5 balance (Schwerzenbach, Switzerland). Approximately 8-10 mg samples were analyzed in open aluminum pans, using nitrogen as the purge gas. Samples were heated from 25 to 300°C at a rate of 10°C/ min.
2.2.3.6. Attenuated total reflectance fourier transform infrared spectroscopy (ATR-FTIR). Infrared spectra were recorded on a PerkinElmer Spectrum 1 FT-IR Spectrometer equipped with a UATR and a ZnSe crystal accessory. Each spectrum was scanned in the range of 650-4000 cm −1 with a resolution of 4 cm −1
. Data were evaluated using Spectrum v 5.0.1. software. Four scans of each sample were taken.
Dynamic vapour sorption (DVS).
Vapour sorption experiments were carried out on a DVS Advantage-1 automated gravimetric sorption analyser (Surface Measurement Systems, Alperton, UK) at 25.0 ± 0.1°C. Ethanol was used as the probe vapour. A mass of 15-20 mg of powder was loaded on to the sample basket. Samples were dried for 1 h at 0% relative humidity and then subjected to step changes of 10% RH up to 90% RH, and the reverse for desorption. The sample mass was allowed to reach equilibrium, defined as dm/ dt ≤ 0.002 mg/min over 10 min, before the RH was changed (Grossjohann et al., 2015) . Two cycles of sorption and desorption were performed for each sample. Samples were recovered and analysed by PXRD and DSC.
2.2.3.8. Particle size analysis (PSA). The geometric particle size distributions (PSD) were determined by laser diffraction using a Malvern Mastersizer 2000 (Malvern Instruments Ltd., Worcestershire, UK). Particles were dispersed using a Scirocco dry feeder instrument with 3 bar pressure. An obscuration of 0.5-3% was obtained under a vibration feed rate of 75%. Values reported are D 50 (median particle size) results. Mastersizer 2000 software (Version 5.61) was used for the analysis of the particle size. Results reported are the average of three analyses for each sample.
Scanning electron microscopy (SEM)
The surface images of the samples were captured at various magnifications by SEM using a Zeiss Supra Variable Pressure Field Emission Scanning Electron Microscope (Germany) equipped with a secondary electron detector at 5 kV. Samples were glued on to carbon tabs, mounted onto aluminium pin stubs and sputter-coated with gold/palladium under vacuum prior to analysis.
Intrinsic/constant surface area dissolution studies
The intrinsic dissolution studies of solid materials were performed using a Wood's intrinsic dissolution apparatus (Elementec, Ireland) . This allowed the dissolution to be measured from constant surface area discs. Discs were prepared by compressing the powder (200 mg) into compacts using a PerkinElmer hydraulic press with an 8 mm (diameter) punch and die set at a pressure of 3 tonnes for a 1 min dwell time. The dissolution studies were carried out in phosphate buffer (pH: 7.2, volume: 900 ml, temperature: 37°C) at a rotation speed of 100 rpm as indicated in the USP Pharmacopeia 38/NF 33. All dissolution studies were performed under sink conditions. Aliquots (5 ml) were withdrawn with volume replacement at appropriate time intervals. Samples were filtered through 0.45 µm PTFE filters and analysed for IBU content by HPLC. The study was performed in triplicate. Samples were taken at 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50 and 60 min. The dissolution rate was determined from the slope of the dissolution time profiles over the first 10 min. At the end of the experiments, the discs were recovered, dried at ambient temperature and analysed by PXRD for process induced phase transformation.
For some samples, additional intrinsic dissolution studies were carried out at 20°C, with all other conditions being kept the same.
Statistical analysis of dissolution profiles was performed using DDSolver . Univariate ANOVA analysis was performed to compare drug dissolution profiles considering a p-value < 0.05 as significant (Yuksel et al., 2000) .
High performance liquid chromatography (HPLC)
The concentration of IBU in solution was determined using an Alliance HPLC with a Waters 2695 Separations module system and Waters 2996 photodiode array detector. The mobile phase consisted of 85% HPLC grade methanol and 15% HPLC grade water containing 0.2% trifluroracetic acid (Li et al., 2016) . The mobile phase was degassed by sonicating for 10 min. Separation was performed on a Waters XBridge C18 column with a length of 150 mm, an internal diameter of 3 mm and a particle size of 3.5 μm. Samples were analysed at a UV detection wavelength of 220 nm. An injection volume of 20 μL was used. The elution was carried out isocratically with a flow rate of 0.5 ml/min. The temperature of the column chamber was maintained at 40°C for the entire analytical process. Elution times for IBU and INA were 2.2 and 1.5 min respectively. With the systems containing Soluplus, the ratio of aqueous to organic phase was altered to 70:30 v/v due to peak interference. The elution time for IBU was 5.7 min. Empower software was used for peak evaluation.
Hansen solubility parameter calculation
Hansen solubility parameters were calculated from the chemical structures using the Van Krevelen method (Van Krevelen and Te Nijenhuis, 2009 ). The weight average molecular weights were used to determine solubility parameters for polymeric excipients (Scott, 1992) . The total HSP contribution was divided into three partial solubility parameters: dispersion (δ d ), polar (δ p ) and hydrogen bonding (δ h ). The total solubility parameter was calculated as indicated in Eqs. (1)- (4):
(1) 
where i is the structural group within the molecule, F di is the group contribution of the dispersion forces, F pi is the group contribution of the polar forces, F hi is the group contribution of the hydrogen bonding forces, and V i is the group contribution of the molar volume (Mohammad et al., 2011) .
Results
Single crystal X-ray diffraction characterisation of solvent evaporated cocrystal
Using an equimolar ratio of IBU:INA, the solvent evaporation method produced a colourless crystalline sample of the cocrystal. A suitable crystal was analysed via single crystal X-ray diffraction yielding a formula of C 13 H 18 O 2 :C 6 H 6 N 2 O, a 1:1 cocrystal. The asymmetric unit consists of two independent IBU and two INA molecules, linked via hydrogen bonding, almost as predicted (Li et al., 2016) . Each IBU is disordered over two positions and Fig ). There are several heterosynthon IBU cocrystals known in the literature (Alshahateet, 2010 (Alshahateet, , 2011 Berry et al., 2008; Chen et al., 2010; Stone et al., 2009; Walsh et al., 2003) . Many are trimers e.g. IBU:X:IBU. Only a few display the same packing motif seen here where a tetramer is formed IBU:I-NA:INA:IBU (Alshahateet, 2011; Berry et al., 2008) . Crystallographic data of the cocrystal are presented in Table 1 . (Li et al., 2016) , Bragg peaks attributed to the IBU:INA cocrystal were observed at 6.4°, 17.45°, 18.95°and 20.1°2θ (Fig. 3A) , indicating that the same form of the cocrystal was obtained by both hot melt extrusion and spray drying. Spray drying can produce a different polymorphic form of a cocrystal than other methods of cocrystal formation, as previously seen with the sulfadimidine:4-aminosalicylic acid cocrystal (Grossjohann et al., 2015; Walsh et al., 2018) . However, polymorphism of the IBU:INA cocrystal has not been reported to date. The cocrystal produced by solvent evaporation from isopropanol resulted in more intense Bragg peaks compared to the cocrystals produced by spray drying. Rapid drying processes such as spray drying can result in crystal lattice imperfections such as point defects, line defects and plane defects (Corrigan, 1995) , which in turn can result in phenomena such as small peak shifts and a reduction in peak intensity on the PXRD diffractogram (Ungár, 2004) . Spray dried IBU resulted in crystalline IBU, with the same polymorph obtained as the raw material (Fig. 3A) . Cocrystal formation was observed for the spray dried formulations with mannitol, i.e. SD-M-10, SD-M-30 and SD-M-50 formulations (Fig. 3B) . Bragg peaks attributable to the individual cocrystal components were not observed. However, Bragg peaks attributable to both the cocrystal and to different polymorphic forms of mannitol were seen. Both beta and delta mannitol peaks were present in the PXRD diffractogram for all ratios of cocrystal components to excipient (Fig. S4 , Supplementary material). Co-spray drying mannitol with lysozyme has previously been shown to produce a mix of mannitol polymorphs (Hulse et al., 2009 (Table 2 ). It has previously been determined that cocrystallisation can occur when the difference in HSP between the API and coformer is less than 7 MPa 0.5 (Mohammad et al., 2011) , while cocrystal formation in the presence of a third component occured when the difference in HSP between the cocrystal and excipient (i.e. third component) was above 9.6 MPa 0.5 .
Cocrystal formation by spray drying with different ratios of cocrystal components to Soluplus was also assessed. The SD-S-10 formulation resulted in cocrystal formation (Fig. 3D) . The ratio of Soluplus to cocrystal components was increased and cocrystal formation at these ratios was assessed. Bragg peaks attributable to the cocrystal were also observed for the SD-S-15, SD-S-20 and SD-S-30 formulations, as well as crystalline INA and what was taken to be an amorphous phase comprising IBU and Soluplus, given the observed shift in the Tg of Soluplus when loads of ≥15% Soluplus were incorporated into the feed solution. The PXRD patterns of the polymorphic forms of INA were obtained from single crystal data obtained from the Cambridge Crystal Database (Fig. S5, Supplementary material) . Form I (CSD ref code: EHOWIH01) is the unprocessed raw material polymorph used in these experiments (Groom et al., 2016) .
A peak attributable to a polymorph of INA (form IV, CSD ref code: EHOWIH04) can be seen at 23°2θ when Soluplus loads ≥ 15% were incorporated into the process. Attempts were made to co-spray dry the cocrystal components with Soluplus at a ratio of 60:40 (w/w). However, when this ratio was used, the yield was significantly affected, with negligible amounts of product reaching the collection vessel of the spray dryer. Cocrystal formation, without other separated coformer or API components, was only seen when 10% Soluplus was used. Above this excipient loading, a mixture of cocrystal, a glass solution of IBU and Soluplus, and crystalline INA was formed, which can be explained by the fact that the difference in HSP between Soluplus and cocrystal is 2.1 MPa 0.5 . It was previously observed that when the HSP values of cocrystal and excipient are very close, cocrystal formation only occurs when low excipient loads are used . Cocrystal formation in the presence of PVP K15 by spray drying and HME was also assessed. PVP K15 was chosen as, unlike Soluplus, its glass transition temperature was above the extrusion processing temperature (Section 2.2.2). It was hypothesised that this could prevent the formation of a glass solution being formed as a side reaction. A shorter chain PVP was chosen as higher chain length polymers can be more viscous in solution, which can result in kinetic trapping of the API/ coformer during the fast solvent evaporation when spray drying, resulting in the formation of an amorphous dispersion (Paudel et al., 2013) .
Cocrystal formation was assessed by spray drying in the presence of PVP K15 at a ratio of 90:10 (w/w) cocrystal components to excipient. Bragg peaks attributable only to the cocrystal were seen for the SD-P-10 formulation (Fig. 3C ). When the SD-P-20 formulation was processed (w/w), again peaks attributable only to the cocrystal were observed. Due to the abundance of potential hydrogen bonding sites in mannitol, negative controls were prepared to investigate the potential for cocrystal formation between the crystalline excipient (mannitol) and the API or the coformer. PXRD analyses of the control powders showed no new peaks which could be attributed to a 'cocrystal cocktail'. Results of PXRD analyses are presented in Figs. S6-8, Supplementary material. 3.2.1.2. Hot melt extrusion. When the cocrystal components were processed with xylitol, HME-X-10, the hot melt extruded product showed characteristic diffraction peaks of the cocrystal, as well as peaks attributable to crystalline xylitol, which are indicated by arrows (Fig. 4A) . Altering the extrusion temperature and screw configuration has been previously shown to result in cocrystal formation when higher xylitol loads are incorporated into the extrusion process (Li et al., 2017) .
Hot melt extrusion was also performed using Soluplus and PVP K15, HME-S-10 and HME-P-10 respectively, as amorphous excipients. The processing temperature was above the Tg of Soluplus, and below the Tg of PVP K15. In both cases, the presence of cocrystal as well as amorphous and crystalline API/coformer was observed by PXRD (Fig. 4B) . Peaks attributable to INA are highlighted by arrows. However, a cocrystal was obtained with both PVP K15 and Soluplus by spray drying at the same ratio, suggesting that spray drying may offer a processing advantage over hot melt extrusion.
Negative controls were also prepared with xylitol and the API or coformer to investigate the potential for cocrystal formation between the excipient and the API or coformer. No new peaks attributable to a cocrystal between the excipient and API/coformer were observed. Results of PXRD analyses are presented in Figs. S9-11 INA displaying a polymorphic transformation at 120.08 ± 0.63°C (13.34 ± 0.06 J/g) and a melting point at 156.40 ± 0.13°C (196.14 ± 0.57 J/g) ( Fig. 5A and Table 3 ). For the physical mixture of IBU and INA, two endothermic events were present, one of which was below the IBU melt temperature, which may be attributed to a eutectic melt. In systems forming eutectics, cocrystal formation can occur by heating in the DSC past the eutectic temperature (Lu et al., 2008) . The second endotherm can be attributed to the cocrystal. No thermal event attributable to INA was observed.
Xylitol displayed a characteristic melting point at 93.68 ± 0.16°C (249.56 ± 9.15 J/g) (Fig. 6A) , while mannitol had one endothermic event characteristic of melting at 165.59 ± 0.21°C (307.14 ± 5.87 J/ g) (Fig. 5B) . The spray dried product of IBU and INA from ethanol at a 1:1 M ratio displayed one endothermic peak at 119.33 ± 0.14°C (139.10 ± 0.98 J/g) and no exothermic peaks, indicating that cocrystal formation had occurred. The spray dried cocrystal from isopropanol displayed an endothermic peak at 119.31 ± 0.16°C (138.64 ± 0.25 J/g), similar to that of the cocrystal produced by spray drying from ethanol with a slight reduction in the melt enthalpy. Solvent evaporation from isopropanol resulted in a material that displayed one single endothermic peak in the DSC at 119.72 ± 0.09°C (139.43 ± 0.56 J/g) ( Table 4) . Co-spray dried IBU:INA with mannitol at all three ratios, SD-M-10, SD-M-30 and SD-M-50, displayed two melting peaks, one attributable to the melting of the cocrystal and one attributable to the melting of crystalline mannitol (Fig. 5B) . No melting peaks attributable to the individual cocrystal components were observed, even when high mannitol loads (50 %w/w) were incorporated into the feed solution prior to spray drying. Melting point depression of the cocrystal was observed with increasing mannitol loads, as well as broad melting peaks. This was observed for both the co-spray dried systems and the physical mixtures of cocrystal and mannitol. Melting point depression and broad melting peaks were also seen for mannitol. The melting enthalpy of the co-spray dried systems and the physical mixtures were compared and the relative crystallinity of the co-spray dried systems compared to a physical mixture of cocrystal and excipient was calculated. A relative crystallinity of 98.36%, 97.43% and 91.79% was calculated for the SD-M-10, SD-M-30 and SD-M-50 formulations respectively, showing a small loss in crystallinity for the co-spray dried formulations compared to the physical mixtures.
The SD-S-10 formulation resulted in cocrystal formation, with one endothermic peak present on the DSC curve, which can be attributed to cocrystal melting (Fig. 5C ). When the ratio of Soluplus in the feed solution was increased, a second endothermic event was observed directly after cocrystal melting. However, this shoulder peak was not present in physical mixtures of spray dried cocrystal and Soluplus at the same ratios (Fig. S12, Supplementary material) . This double melting peak could be attributed to two different crystal morphologies (Blundell, 1987) . Nevertheless, as this peak occurred after cocrystal melting, it is unlikely to be morphology related. This peak can probably be attributed to a significantly depressed INA melting event which can be observed when 15%, 20% and 30% Soluplus was incorporated into the feed solution prior to spray drying.
A polymorphic form of INA (form IV, CSD ref code: EHOWIH04) was generated, as well as the cocrystal, when Soluplus loads ≥ 15% were used. This polymorph was also generated when INA was spray dried with Soluplus (50:50 wt ratio), resulting in one endothermic event at 140°C (Fig. S13, Supplementary material ). This polymorph has been shown to demonstrate one endothermic event on DSC analysis. No phase change is seen during DSC analysis, as only a melting event is observed (Eccles et al., 2011) . At Soluplus loads ≥ 15 %, a mixture of an amorphous phase, cocrystal and crystalline INA can be observed. When ≥15 % Soluplus is incorporated into the feed solution, a shift in the Tg of Soluplus is seen, indicating a glass solution of polymer and IBU is formed, as well as crystalline INA. mDSC results are presented in Fig. S14 , Supplementary material, which shows the shift in glass transitions of the systems with ≥15% Soluplus. The relative crystallinities of the co-spray dried samples were obtained by comparing the melt enthalpies to the relevant physical mixtures of cocrystal and Soluplus. A relative crystallinity of 94.11%, 66.68%, 56.58% and 32.69% was calculated for the systems containing 10%, 15%, 20% and 30% of Soluplus respectively, indicating a significant amount of amorphous IBU, present as a glass solution with Soluplus, and crystalline INA are present in the formulations containing ≥15% Soluplus.
The SD-P-10 formulation showed one endothermic peak at the cocrystal melting temperature (Fig. 5D ). The relative crystallinity of the co-spray dried product compared to the physical mixture of cocrystal and PVP was 98.94%. A Tg was observed at 10.66 ± 0.67°C, indicating the presence of a glass solution between the polymer, API and/ or coformer. A melting event of the individual components was not observed. It was not possible to determine if a separate phase of polymer was present, as the Tg of this was obscured by the melting of the cocrystal. The SD-P-20 formulation showed two endothermic peaks, one attributable to the cocrystal and a second peak after the cocrystal temperature. Like the systems with ≥15% Soluplus, this can be attributed to crystalline INA, although this was not detected by PXRD. A Tg was also observed at 3.65 ± 0.28°C, which is likely a glass solution of polymer, IBU and/or INA, Fig. S15 , Supplementary material.
Hot melt extrusion.
The HME-X-10 formulation displayed two characteristic melting peaks, a depressed xylitol peak at 84.95 ± 0.16°C (21.98 ± 0.82 J/g) and a cocrystal melting peak at 115.28 ± 0.07°C (119.66 ± 2.27 J/g) (Fig. 6A) . The melting enthalpy of the hot melt extruded cocrystal in xylitol was slightly lower than the spray dried cocrystal in mannitol. However, this may be attributed to the cocrystal melting into liquid xylitol in the case of the hot melt extruded product, while the cocrystal melts in the presence of solid mannitol in the case of the spray dried product. A relative crystallinity of 97.99% was measured for the hot melt extruded product compared to the physical mixture of cocrystal and xylitol. The hot melt extruded products with Soluplus and PVP K15 were also analysed (Fig. 6B) . The HME-S-10 formulation showed an endothermic peak attributable to a eutectic melting, as well as a cocrystal melt. It is likely that the eutectic phase comprises IBU and INA, as Bragg peaks attributable to INA were observed in the PXRD diffractogram (Fig. 4B) . The HME-P-10 formulation showed a melting event attributable to the cocrystal, as well as a depressed INA melt, indicating that only crystalline INA was observed by DSC, and any excess IBU was rendered amorphous.
It should be noted that TGA experiments were performed on the raw materials prior to HME to demonstrate suitability of the processing temperatures used. All chemicals showed less than 5% mass loss at the extrusion processing temperature, with the exception of PVP K15. However, the weight loss observed for PVP K15 can mainly be attributed to water loss. Results of TGA experiments can be seen in Fig. S16 , Supplementary material.
Investigation of H-bonding interactions by Fourier transform infrared spectroscopy
The FTIR spectra of IBU, INA, cocrystal, mannitol, xylitol, Soluplus, PVP K15, the hot melt extruded system with xylitol and the spray dried formulations with mannitol, Soluplus and PVP K15 are presented in Fig. 7 . Cocrystal formation between an API and coformer can form between supramolecular heterosynthons or homosynthons (Desiraju, 1995) . The FTIR spectrum for IBU showed a broad vibrational band from 3400 to 2800 cm −1 , characteristic of OeH stretching of the carboxylic acid group. Medium intensity peaks are observed from 3100 to 2900 cm
, representing CeH stretching in the CeH, CeH 2 and CeH 3 groups of IBU and the CeH bonds in the aromatic ring (Vueba et al., 2008) . A strong band was present at 1708 cm −1 , indicative of stretching of the C]O group of the carboxylic acid (Maheshwari et al., 2003) . Weak bands at 1008 cm −1 were representative of CeC stretching (Fig. 7A) . INA showed vibrational bands at 3361 cm −1 and 3178 cm
, representing asymmetric and symmetric stretching NeH respectively, for the H-bonded primary amide groups among closely packed INA molecules (Bakiler et al., 2007; Iogansen et al., 1977) . Vibrational stretching at 1654 cm −1 represented the amide carbonyl group, while 1621 cm −1 represented bending of the NeH bond in the primary amide (Filho et al., 2006) . Some shifts in the IR peaks were observed for the cocrystal (prepared by spray drying) when compared to a physical mixture of IBU and INA, which can be attributed to H-bonding interactions between the two components. The IBU:INA cocrystal consists of two acid:amine interactions and an amide homodimer between the INA molecules. INA contains two competing H-bond acceptor sites, the pyridine N and the amide carbonyl. The nitrogen on the pyridine ring is considered a stronger H-bond acceptor than the amide carbonyl (Laurence and Berthelot, 2000) . In crystalline INA, the pyridine N forms a hydrogen bond with the amide NeH. This bond is broken in the cocrystal, resulting in the formation of an N-H , resulting in the formation of the amide homodimer (Chow et al., 2012) .
The broad peak attributable to OeH stretching in IBU is absent for the cocrystal, with the formation of a single peak at 3317 cm −1 , which can be attributed to H-bonding between the pyridine N and the OeH group of the carboxylic acid of IBU. The carboxylic acid carbonyl of IBU shifted from 1708 cm −1 to 1698 cm −1
, due to H-bond formation between the carbonyl and the pyridine hydrogen. The CeH bending of the pyridine ring also shifted from 794 cm −1 to 779 cm −1 . The same peaks were present when the API and coformer was co-spray dried with mannitol, xylitol, PVP K15 and Soluplus, and the hot melt extruded product with xylitol, as well as peaks attributable to the excipient, indicating that cocrystal formation occurred in the presence of the excipient (Fig. 7A-D) .
3.2.4. Moisture uptake and sorption-desorption profile DVS analysis of the spray dried cocrystal, the spray dried formulations with mannitol and Soluplus and the hot melt extruded cocrystal with xylitol was performed using ethanol as the probe vapour. Initial 
Table 4
Summary table including thermal events of all spray dried and hot melt extruded systems. The ratio of IBU:INA cocrystal was 1:1 M ratio for all systems. International Journal of Pharmaceutics 551 (2018) 241-256 experiments were performed using water as the adsorbate. However, due to the hydrophobic nature of IBU, samples showed negligible water uptake (data not shown). The sorption and desorption isotherms of the formulations are illustrated in Fig. 8 . The maximum ethanol sorption of the spray dried cocrystal was 0.54% ( Fig. 8A and B) , with most vapour uptake being between 50 % and 90 % RH. The desorption profile showed a hysteresis effect from 90 % to 40 % RH. No hysteresis effect was seen on the second cycle. The spray dried formulations with mannitol showed a maximum ethanol sorption of 0.93 %, 1.63 % and 2.88 % for the SD-M-10, SD-M-30 and SD-M-50 formulations respectively. The increase in ethanol uptake with increasing mannitol loads may be due to the high surface area of the porous, spray dried mannitol particles (Littringer et al., 2011; Maa et al., 1997) . The HME-X-10 formulation showed a maximum moisture uptake of 0.33 % at 90 % RH, showing a hysteresis at all points from 90 % to 20 % RH. A significant difference in moisture uptake between the first and second cycles was not seen for any system, indicating that the spray dried samples contained a negligible amorphous content prone to crystallisation. The samples were recovered and analysed by PXRD and DSC. No change in solid form was observed with any of the systems containing mannitol as carrier excipient post DVS analysis (Fig. 8C) . The co-spray dried systems with Soluplus all showed a significantly higher moisture uptake than the co-spray dried systems with mannitol. This can be mainly attributed to the amorphous nature of Soluplus. However, no hysteresis effect was observed at any RH step. The ethanol uptake at 90 % RH was 8. 29, 14.01, 18.65 and 28.64 (% w/w) for the SD-S-10, SD-S-15, SD-S-20 and SD-S-30 formulations respectively. PXRD analysis of these systems after DVS showed a Bragg peak attributable to INA at 23°2θ for systems containing ≥ 15% Soluplus. This is not the case for the SD-S-10 formulation, as only peaks attributable to the cocrystal were present, suggesting that any amorphous content in this system crystallises to the cocrystal, or is stable as a glass solution at this ratio (Fig. 8D ).
Particle size distribution (PSD)
PSD analysis of the spray dried formulations and hot melt extruded formulation were evaluated (Table 5) . Spray drying resulted in a particle size reduction when compared to the raw API and coformer materials. The spray dried cocrystal displayed a D 50 of 6.92 ± 0.13 μm. A similar particle size was measured in the hot melt extruded product with xylitol after cryomilling (6.63 ± 0.36 μm). An increase in D 50 was observed when mannitol was added compared to the cocrystal spray dried alone, with the largest particle size being the formulation containing 50% mannitol. The samples which resulted in cocrystal formation with the amorphous excipients, Soluplus and PVP K15, displayed a 1.7 and 1.6-fold higher D 50 value of 11.75 ± 0.27 μm and 10.95 ± 0.46 μm, respectively, compared to the spray dried cocrystal without excipients.
Morphology characterisation by SEM
The spray dried IBU:INA cocrystal presented as plate shaped particles, with a significantly smaller particle size than the raw materials (Fig. 9) . Co-spray drying of the cocrystal components with mannitol and Soluplus resulted in cocrystal plates, whereas more spherical particles were obtained when PVP K15 was used as the carrier excipient. The smaller particle size of the spray dried particles could result in poorly flowing and cohesive powder from a manufacturing point of view, but this could be negated by altering spray drying parameters, such as decreasing the airflow of the drying gas, and increasing the feed rate and concentration of the feed solution (Cal and Sollohub, 2009) ; however, this is not the main aim of this work and has not been further investigated.
Dissolution studies
Constant surface area dissolution studies of the spray dried cocrystal, HME-X-10, SD-M-10, SD-S-10 and SD-P-10 were performed ( Fig. 10A and B) . Intrinsic dissolution studies of unprocessed IBU were also performed (Fig. S17, Supplementary material) .
Dissolution studies of the cocrystal, SD-M-10 and HME-X-10 all resulted in similar dissolution profiles. All three formulations showed a similar IDR and release after 60 min. The SD-S-10 formulation showed a lower release compared to the cocrystal, while the SD-P-10 formulation showed a higher release compared to the reference cocrystal. This formulation showed a 2.3-fold greater IDR for IBU compared to the spray dried cocrystal as well as the highest release of IBU after 60 min amongst all the tested formulations. The highest release was for the unprocessed raw material. However, it is important to note that the starting material is different for this system, as IBU is the starting material as opposed to the cocrystal. The dissolution studies were performed in pH 7.2 phosphate buffer, a medium in which IBU is very soluble (Dhingra et al., 2010) . The pH-solubility curve for cocrystals can be significantly different to that of the API (Bethune et al., 2009) , which can in turn impact dissolution of the API. Therefore, dissolution of the unprocessed API may not be directly comparable with dissolution from the cocrystal when pH-solubility studies of the cocrystal have not been performed. These experiments have not been performed as part of this study.
Univariate ANOVA analysis was also performed to compare the dissolution profile of the spray dried cocrystal to the dissolution profiles of the co-spray dried and hot melt extruded formulations. The co-spray dried system with PVP was the only system which was statistically significantly different from the reference at each time point, indicating the IDR of this system was statistically higher than that of the cocrystal, as was the total release after 60 min.
Exposure of the cocrystal to the dissolution medium resulted in the transformation of the cocrystal to the individual components (Fig. 10C) . PXRD analysis of the surface of the disk after dissolution revealed peaks attributable mainly to IBU. No INA peaks were observed, suggesting that the more soluble INA was in solution, leaving the less soluble IBU on the surface of the disk. A cocrystal peak was also present at 17.4 2θ. It has previously been reported that when a large difference in solubility exists between the API and the coformer, the cocrystal can be unstable in solution and recrystallization to the individual components can occur. Recrystallization to individual components is less likely to occur when the solubilities of the API and coformer are similar (Schultheiss and Newman, 2009 ). Transformation to the individual components was also observed when the hot melt extruded cocrystal with xylitol and the spray dried cocrystal with mannitol were analysed by PXRD after dissolution ( Fig. 10D and E) . Bragg peaks attributable to IBU are indicated by arrows. Analysis of the disk after dissolution of the SD-S-10 formulation showed the same diffraction peaks as the cocrystal, indicating that Soluplus polymers prevented the recrystallization of the cocrystal to the individual components (Fig. 11A) . For the SD-P-10 formulation, PXRD analysis of the disk after dissolution showed mainly Bragg peaks attributable to the cocrystal. However, a characteristic peak of IBU at 6.15°can also be seen, suggesting some recrystallisation to the individual components, or crystallisation of trace amounts of amorphous IBU present in the system. (Fig. 11B) .
The lowest IDR and release after 60 min of IBU was for the spray dried system with Soluplus (Table 5) . However, the low IDR may be due to the presence of Soluplus as this excipient exhibits a lower critical solution temperature (LCST) in water near 40°C (Hughey et al., 2013 ). Polymers can demonstrate good aqueous solubility at low temperature, but can demonstrate partial miscibility and separate from solution above the LCST (Feil et al., 1993) . At the LCST, Soluplus chains lose hydration and progressively associate, decreasing their solubility and forming a cloudy suspension that can precipitate. This behaviour is responsible for the gel-forming property of Soluplus (Fini, 2016) . Attempts to measure the IDR of IBU and carvedilol from solid dispersions containing Soluplus have resulted in lower values than expected, which has been attributed to the gelling properties of Soluplus (Genina et al., 2017) .
To test our hypothesis that the lower release of IBU from the cospray dried system with Soluplus was due to the LCST of Soluplus, dissolution studies of both this system and the spray dried cocrystal were performed at 20°C (Fig. 10B) . The dissolution rate of the cocrystal was significantly (p less than 0.05) lower than that of the co-spray dried 11.40 ± 0.57 -SD-S-10 11.75 ± 0.27 0.152 ± 0.006 SD-P-10 10.95 ± 0.46 0.454 ± 0.022 HME-X-10 6.63 ± 0.36 0.207 ± 0.004 Walsh et al. International Journal of Pharmaceutics 551 (2018) 241-256 system with Soluplus at 20°C. Disks were also analysed by PXRD after dissolution. Similar to the results obtained at 37°C, the diffractogram of the SD-S-10 formulation after dissolution showed the same Bragg peaks of the cocrystal after dissolution. However, the cocrystal without a carrier excipient showed Bragg peaks attributable to IBU and also multiple cocrystal peaks, which differs from results at 37°C. This can be explained by the higher temperature, which may accelerate the dissociation of the cocrystal into its individual components.
Discussion
The comparison of spray drying versus HME in order to formulate amorphous solid dispersions has been widely studied. For spray drying, the solubility of the drug in the solvent is crucial in order to ensure a readily scalable and viable process whereas for HME, the solubility of the drug in the polymer is key to achieve a thermodynamically stable formulation. From an industrial point of view, the phase of development is also important in process selection. Bearing in mind that API availability is often limited at early-stages, spray drying is preferable because its feasibility can be determined with amounts as low as 50-100 mg (Dobry et al., 2009 ), whereas at least several grams of API are required for HME (Guns et al., 2012) . In spite of the use of solvents, spray drying is often preferred over HME for several reasons such as thermally induced degradation of the drug (Hengsawas Surasarang et al., 2017) , phase separation (Lenz et al., 2017) and high shear forces during the HME process (Guns et al., 2010) . To the best of our knowledge, the feasibility of employing both techniques to form of cocrystals within a carrier excipient has not been compared. In order to ensure cocyrstal formation, the H-bonding interaction between API and coformer has to be stronger than the interaction of the individual components with the carrier excipient. Otherwise, cocrystal integrity will not be preserved.
HSP differences have been previously employed as a useful, reliable tool to predict cocrystal formation in the presence of a carrier excipient. It was previously reported that, for immiscible systems (with a difference in HSP between the cocrystal and excipient > 9.6 MPa 0.5 ), cocrystal formation occurred even when the proportion of excipient was high (up to 80 % w/w) when processed by spray drying. However, HSP differences should not be used as the only indicator for cocrystal formation, as the ratio of carrier excipient: cocrystal also has a major impact as well as the miscibility among the three components (drug, coformer and carrier). When the difference in HSP between the cocrystal and the excipient is very small, the cocrystal integrity can still be preserved at low excipient ratios . The impact of HSP differences has been demonstrated again in the current study for the IBU:INA cocrystal: excipient systems produced by spray drying. When the difference in HSP between the cocrystal and the excipient was greater than 9.6 MPa 0.5 , as in the case of mannitol (ΔHSP of 18.3 MPa 0.5 ), larger amounts of excipient, up to 50 %, could be incorporated during the spray drying process without altering the integrity of the cocrystal. For the other two tested excipients, Soluplus and PVP K15 where the difference in HSP (between the cocrystal and excipient) was much lower, at 2.1 and 1.6 MPa 0.5 respectively, the IBU:INA cocrystal was only formed when very low amounts of excipient (10 %) were used. Remarkably different results were obtained when HME was employed for processing. In the case where xylitol was used as the excipient carrier, with a difference in HSP (between the cocrystal and excipient) of 20.7 MPa 0.5 , a similar order of magnitude as that for mannitol, pure cocrystal (devoid of API or coformer contaminants) resulted on co-processing by HME. While it has been reported that cocrystal formation can occur even with high xylitol loads (50 %w/w), this required alteration of the extrusion elements and processing temperature (Li et al., 2017) . Spray drying may be seen as a more robust process as alteration of spray drying parameters was not required to produce a cocrystal with high mannitol loads. In the case of Soluplus and PVP K15, a mixture of cocrystal with single components was obtained with only 10 % excipient, while the equivalent spray dried systems showed cocrystal with no contaminating API or coformer staring materials could be prepared at the equivalent weight ratios.
The different results obtained between spray drying and HME are probably related to the speed of the processes and the energy (mechanical and thermal) imparted during mixing of the cocrystal components and the excipient. The evaporation of the solvent during the spray drying process takes place in milliseconds and hence, there is less chance for the cocrystal to interact within the excipient molecules, whereas the mixing of the components in HME is a more energetic and longer process, potentially facilitating interactions between the cocrystal components and the excipients. For this reason, highly immiscible systems (cocrystal: excipient) are required to guarantee selective H-bond interactions between the drug and the coformer molecules and probably larger differences in HSP are necessary to ensure cocrystal formation in HME processes.
Conclusions
Cocrystallisation of an API and coformer in the presence of an excipient can be achieved through both spray drying and hot melt extrusion. However, the results obtained with the IBU:INA cocrystal suggest greater feasibility of spray drying over HME as a process for producing cocrystals within a carrier excipient, intended to reduce the number of unit operations required to produce a final pharmaceutical product. The use of HSP differences can be useful to predict cocrystal formation within a carrier excipient. However, ΔHSP values should not be used as the only indicator, as the manufacturing process, the ratio of carrier excipient:cocrystal and the overall miscibility among drug, coformer and carrier have also a major impact. 
